VBI Vaccines Inc/BC Share-based Payment Arrangement, Expense
VBI Vaccines Inc/BC reported Share-based Payment Arrangement, Expense of $2.41 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-02-26.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2018-02-26
- VBI Vaccines Inc/BC share-based payment arrangement, expense for the quarter ending 2017-12-31 was $566.00K, a 1.43% increase year-over-year.
- VBI Vaccines Inc/BC share-based payment arrangement, expense for the quarter ending 2017-09-30 was $593.00K, a 15.53% decline year-over-year.
- VBI Vaccines Inc/BC share-based payment arrangement, expense for the quarter ending 2017-06-30 was $627.00K, a 39.83% decline year-over-year.
- VBI Vaccines Inc/BC share-based payment arrangement, expense for the quarter ending 2017-03-31 was $624.00K.
- VBI Vaccines Inc/BC share-based payment arrangement, expense for fiscal 2017 was $2.41M, a 4.69% increase from fiscal 2016.
- VBI Vaccines Inc/BC share-based payment arrangement, expense for fiscal 2016 was $2.30M.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|
| 2017-12-31 | $566.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $1.16M derived: sum of 2 quarters · filed 2018-02-26 | $1.79M derived: sum of 3 quarters · filed 2018-02-26 | $2.41M 10-K · filed 2018-02-26 |
| 2017-09-30 | $593.00K 10-Q · filed 2017-11-13 | $1.22M derived: sum of 2 quarters · filed 2017-11-13 | $1.84M 10-Q · filed 2017-11-13 | $2.40M derived: sum of 4 quarters · filed 2018-02-26 |
| 2017-06-30 | $627.00K 10-Q · filed 2017-07-31 | $1.25M 10-Q · filed 2017-07-31 | $1.81M derived: sum of 3 quarters · filed 2018-02-26 | $2.51M derived: sum of 4 quarters · filed 2018-02-26 |
| 2017-03-31 | $624.00K 10-Q · filed 2017-05-15 | $1.18M derived: sum of 2 quarters · filed 2018-02-26 | $1.88M derived: sum of 3 quarters · filed 2018-02-26 | $2.93M derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-12-31 | $558.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $1.26M derived: sum of 2 quarters · filed 2018-02-26 | $2.30M derived: sum of 3 quarters · filed 2018-02-26 | $2.30M 10-K · filed 2018-02-26 |
| 2016-09-30 | $702.00K 10-Q · filed 2017-11-13 | $1.74M derived: sum of 2 quarters · filed 2017-11-13 | $1.74M 10-Q · filed 2017-11-13 | |
| 2016-06-30 | $1.04M 10-Q · filed 2017-07-31 | $1.04M 10-Q · filed 2017-07-31 |